Atara Biotherapeutics (ATRA) Receivables - Net (2022 - 2025)
Historic Receivables - Net for Atara Biotherapeutics (ATRA) over the last 4 years, with Q3 2025 value amounting to $1.9 million.
- Atara Biotherapeutics' Receivables - Net rose 4329.59% to $1.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.9 million, marking a year-over-year increase of 4329.59%. This contributed to the annual value of $1.5 million for FY2024, which is 9565.5% down from last year.
- As of Q3 2025, Atara Biotherapeutics' Receivables - Net stood at $1.9 million, which was up 4329.59% from $8.9 million recorded in Q1 2025.
- Atara Biotherapeutics' 5-year Receivables - Net high stood at $40.2 million for Q4 2022, and its period low was $163000.0 during Q3 2023.
- For the 4-year period, Atara Biotherapeutics' Receivables - Net averaged around $9.2 million, with its median value being $1.4 million (2024).
- Over the last 5 years, Atara Biotherapeutics' Receivables - Net had its largest YoY gain of 892619.65% in 2024, and its largest YoY loss of 9565.5% in 2024.
- Atara Biotherapeutics' Receivables - Net (Quarter) stood at $40.2 million in 2022, then fell by 15.2% to $34.1 million in 2023, then crashed by 95.65% to $1.5 million in 2024, then grew by 29.08% to $1.9 million in 2025.
- Its last three reported values are $1.9 million in Q3 2025, $8.9 million for Q1 2025, and $1.5 million during Q4 2024.